Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates
about
sameAs
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugatesDevelopment, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodiesPreparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugatesMolecular characterization of the 98-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis.Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.Comparative analysis of two meningococcal immunotyping monoclonal antibodies by resonant mirror biosensor and antibody gene sequencingConservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis.Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis.Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.Current status of meningococcal group B vaccine candidates: capsular or noncapsular?Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis.
P2860
Q28333417-79B3D029-D333-449B-B2EC-9D7E673FF4B8Q28378767-B1E20F27-67F9-410D-B614-868CD3EB286EQ33595722-D04F2990-B946-409C-80E4-3AF9FC1D31D6Q33614142-4B06691F-0F42-44DC-8479-31A100560305Q33753424-40C7F973-2703-4CB0-8EDF-A3781844F21BQ33997977-9C69585A-D026-4D9B-8F37-F2530E41F25EQ34002209-05A2D0C5-96F6-4527-A232-9D2506EA1F47Q34119002-8DBA41F5-69B3-40CB-99B9-EC6FF28E8F61Q34521522-EA2C0F66-BDFC-4D36-8284-5AA2FBEC5DEDQ35273041-46C52AAE-2916-4507-A862-F93397D9D538Q36642138-AD1017F2-5AE8-40EE-8AEB-E3D5EC4A4578Q36989971-373B5DAA-F87C-4158-8D9B-16B04D340E91Q37058833-FEE91231-B4D1-4D62-BBF4-58A4185261E7Q40147293-230879FD-240D-4E06-9F09-6B1B589BB4F5
P2860
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates
description
1991 nî lūn-bûn
@nan
1991 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մարտին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Preparation, characterization, ...... osaccharide-protein conjugates
@ast
Preparation, characterization, ...... osaccharide-protein conjugates
@en
Preparation, characterization, ...... osaccharide-protein conjugates
@nl
type
label
Preparation, characterization, ...... osaccharide-protein conjugates
@ast
Preparation, characterization, ...... osaccharide-protein conjugates
@en
Preparation, characterization, ...... osaccharide-protein conjugates
@nl
prefLabel
Preparation, characterization, ...... osaccharide-protein conjugates
@ast
Preparation, characterization, ...... osaccharide-protein conjugates
@en
Preparation, characterization, ...... osaccharide-protein conjugates
@nl
P2093
P2860
P1476
Preparation, characterization, ...... osaccharide-protein conjugates
@en
P2093
Hoogerhout P
Leenhouts JM
Poolman JT
Verheul AF
P2860
P304
P407
P577
1991-03-01T00:00:00Z